Humana Inc vs Yum! Brands, Inc. — how do they compare? Humana Inc trades at $374.25 (market cap $46.31B), while Yum! Brands, Inc. trades at $144.74 (market cap $39.66B). The key difference: Humana Inc is the larger of the two by market cap, and Yum! Brands, Inc. pays the higher dividend (2.06%). Which is the better fit depends on your goals.
| HUM | YUM | |
|---|---|---|
Market Cap | $46.31B | $39.66B |
Sector | Health | Consumer Cyclical |
52-Week High | $409.42 | $168.16 |
52-Week Low | $163.67 | $138.21 |
Enterprise Value | $53.67B | $51.26B |
Dividend Yield | 0.92% | 2.06% |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
YUM trades at $150.76, down 0.95% on the day, amid a bearish technical signal and recent sales headwinds from a parasite outbreak affecting Taco Bell. The company reported Q2 2026 EPS of $1.62, beating estimates, and completed the $1.2 billion sale of Pizza Hut China. Revenue growth is steady, with 2025 revenue at $8.21 billion and net income margin of 25.4%, though debt remains elevated. Analyst consensus is a Buy with a $174.60 price target, but legal investigations and food safety concerns present near-term risks.
The outlook is mixed: strong digital growth and portfolio streamlining offer upside, but the stock faces pressure from the cyclospora outbreak's impact on sales and ongoing fraud probes. Investors should weigh solid fundamentals against sentiment-driven volatility and high leverage.
Trailing returns across standard periods
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →Yum Brands is a U.S.-based restaurant operator featuring a portfolio of four brands: KFC (26,930 global units), Pizza Hut (18,380 units), Taco Bell (7,790 units), and The Habit Burger (310 units) at year-end 2021. With $58 billion in 2021 systemwide sales, the firm is the second-largest restaurant company in the world, behind McDonald's ($112.5 billion) but ahead of Restaurant Brands International ($36 billion) and Starbucks ($25 billion). Yum is 98% franchised, with the largest franchisee, Yum China, created via a 2016 spinoff transaction (after which Yum China agreed to pay 3% royalties to Yum Brands in perpetuity). Yum is the newest evolution of Tricon Brands, formerly a division of PepsiCo, and generates the bulk of its revenue from franchise royalties and marketing contributions.
Read more on YUM →